Abstract

Production of antibodies in chickens (IgY) has significantly attracted attention of scientists. Numerous publications have reported use of IgY in diagnosis, therapy and prophylaxis. Production of antigen-specific antibodies in chicken can help treat and prevent infectious diseases. The aim of this study was to assess the safety of IgY( anti E. coli O157:H7) on the antioxidant system in mice .Therefore in this study, three different doses of IgY against E. coli O157:H7 (0.9375, 1.875 and 3.75 g / kg) were administrated through oral route to 18 mice (treated groups) and PBS to the control group and 14 days after administration, blood samples were collected from the mice. Serum malondialdehyde (MDA) level and catalase, glutathione peroxidase and superoxide dismutase activity were measured using commercial kits. Oral administration of IgY against E. coli O157:H7 in doses of 0.9375, 1.875 and 3.75 g / kg caused no deaths and showed no toxic effects on mice. In this study, after 14 days of IgY administration there were no significant changes in the activity of antioxidant enzymes (catalase, glutathione peroxidase and superoxide dismutase) and MDA serum level compared to the control group. Our findings revealed that oral administration of IgY against E. coli O157:H7 does not show any toxic effects and does not disturb the antioxidant system in mice . These findings could be indicative of safety of oral administration of IgY in mice.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.